RT Journal Article
T1 Effects of ABO Matching of Platelet Transfusions in Critically Ill Children.
A1 Nellis, Marianne E
A1 Goel, Ruchika
A1 Karam, Oliver
A1 Cushing, Melissa M
A1 Davis, Peter J
A1 Steiner, Marie E
A1 Tucci, Marisa
A1 Stanworth, Simon J
A1 Spinella, Philip C
A1 Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, Pediatric Critical Care Blood Research Network (BloodNet), and the P3T Investigators
A1 P3T Investigators, 
AB To determine if transfusing ABO compatible platelets has a greater effect on incremental change in platelet count as compared to ABO incompatible platelets in critically ill children. Secondary analysis of a prospective, observational study. Transfusions were classified as either ABO compatible, major incompatibility, or minor incompatibility. The primary outcome was the incremental change in platelet count. Transfusion reactions were analyzed as a secondary outcome. Eighty-two PICUs in 16 countries. Children (3 d to 16 yr old) were enrolled if they received a platelet transfusion during one of the predefined screening weeks. None. Five-hundred three children were enrolled and had complete ABO information for both donor and recipient, as well as laboratory data. Three-hundred forty-two (68%) received ABO-identical platelets, 133 (26%) received platelets with major incompatibility, and 28 (6%) received platelets with minor incompatibility. Age, weight, proportion with mechanical ventilation or underlying oncologic diagnosis did not differ between the groups. After adjustment for transfusion dose, there was no difference in the incremental change in platelet count between the groups; the median (interquartile range) change for ABO-identical transfusions was 28 × 10 cells/L (8-68 × 10 cells/L), for transfusions with major incompatibility 26 × 10 cells/L (7-74 × 10 cells/L), and for transfusions with minor incompatibility 54 × 10 cells/L (14-81 × 10 cells/L) (p = 0.37). No differences in count increment between the groups were noted for bleeding (p = 0.92) and nonbleeding patients (p = 0.29). There were also no differences observed between the groups for any transfusion reaction (p = 0.07). No differences were seen in the incremental change in platelet count nor in transfusion reactions when comparing major ABO incompatible platelet transfusions with ABO compatible transfusions in a large study of critically ill children. Studies in larger, prospectively enrolled cohorts should be performed to validate whether ABO matching for platelet transfusions in critically ill children is necessary.
SN 1529-7535
YR 2019
FD 2019
LK http://hdl.handle.net/10668/13179
UL http://hdl.handle.net/10668/13179
LA en
DS RISalud
RD Apr 7, 2025